All Articles

The waffle giant is helping restaurants meet health demands with simple add-ins that boost nutrition without disrupting kitchen workflow or taste.

From 90s trends to green innovations, Canada's top salon chain celebrates 35 years of style, sustainability, and putting its stylists first.

A historic 142 deals and $1.67 trillion in assets changed hands in Q1 2026, as private equity, tech, and global ambitions fuel a record consolidation wave.

A new partnership offers employees interest-free financing for out-of-pocket medical costs, tackling a key barrier to care and boosting employer benefits.

Following a record 10.7 million visitors, The Palm Beaches are unveiling a wave of new hotels, restaurants, and cultural hubs. But can the boom be sustained?

Maine's tourism office is using AI to create personalized trip plans, guiding visitors to hidden gems and boosting local economies across the Pine Tree State.

From hard-hitting nonfiction to lyrical poetry, the 16 Trillium finalists showcase the artistic diversity and economic power of Ontario's literary scene.

A new all-in-one system from Sweden's Multi4 Medical just won EU approval, allowing urologists to treat bladder cancer in minutes without surgery.

Diagnostic leader Bracco enters the cell therapy market with BubbleGen, a novel microbubble tech that promises to streamline complex manufacturing.

A songwriter's quest to save an endangered landmark reveals the lost story of America's first major Black opera company and its visionary founder.

Apollo's massive new fund isn't just a win for the firm; it signals a major shift in how companies finance growth in a volatile, high-rate world.

A new national agreement brings QuVa Pharma's AI-powered drug diversion software to thousands of hospitals, promising a high-tech solution to a hidden crisis.

Viant's acquisition of TVision challenges industry giants by pricing TV ads on actual viewership, moving beyond impressions to verifiable human attention.

The global investment bank is buying the boutique firm behind landmark deals for Liverpool FC and the NY Mets to dominate the booming sports finance market.

As the U.S. nears its 250th birthday, a new movement launches a cross-country trek and virtual assembly to mend the nation's fractured soul.

A new blood test could tell you if GLP-1 drugs will work for you before you start, a major leap for precision medicine in the booming obesity market.

A biotech firm is making waves with a non-viral, redosable gene delivery system showing promise for DMD and hemophilia, challenging the industry's reliance on viruses.

With a star-studded new advisory board, Pilatus Biosciences accelerates its attack on cancer's metabolic defenses with its lead drug, PLT012.

Ottobock and Angel City Sports expand their partnership, using advanced tech and community events to build momentum for the LA28 Paralympic Games.

Sensei Biotherapeutics begins a key trial for PIKTOR, a novel oral therapy aiming to outsmart cancer resistance in patients with advanced breast cancer.